Evaluation of Tolerability, Efficacy and Adherence to Treatment With Wynzora Cream

Inclusion Criteria: * Patients older than 18 years of age, of either sex; * Patients diagnosed with mild-to-moderate psoriasis (PASI and BSA \<10) requiring monotherapy topical with Wynzora; * Patients who have stopped treatment with Enstilar foam for any reason for at least 30 days; and * Patients whose medical records are accessible and record all demographic parameters, anthropometric and clinical parameters during the treatment period * Signature of written informed consent; Exclusion Criteria: * Patients with palmoplantar, inverse, erythrodermic, guttate, and scalp psoriasis. * Patients who are taking concomitant systemic therapies for psoriasis, such as. cyclosporine, methotrexate, acitretin, phototherapy or biologic therapies. * Women who are pregnant or planning to become pregnant. * Patients with disabilities or other motor problems that could complicate self-medication.